367 related articles for article (PubMed ID: 35155178)
1. An MRI-Based Radiomics Model for Predicting the Benignity and Malignancy of BI-RADS 4 Breast Lesions.
Zhang R; Wei W; Li R; Li J; Zhou Z; Ma M; Zhao R; Zhao X
Front Oncol; 2021; 11():733260. PubMed ID: 35155178
[TBL] [Abstract][Full Text] [Related]
2. Fully automatic classification of breast lesions on multi-parameter MRI using a radiomics model with minimal number of stable, interpretable features.
Zhang J; Zhan C; Zhang C; Song Y; Yan X; Guo Y; Ai T; Yang G
Radiol Med; 2023 Feb; 128(2):160-170. PubMed ID: 36670236
[TBL] [Abstract][Full Text] [Related]
3. Radiomics Based on DCE-MRI Improved Diagnostic Performance Compared to BI-RADS Analysis in Identifying Sclerosing Adenosis of the Breast.
Ruan M; Ding Z; Shan Y; Pan S; Shao C; Xu W; Zhen T; Pang P; Shen Q
Front Oncol; 2022; 12():888141. PubMed ID: 35646630
[TBL] [Abstract][Full Text] [Related]
4. Multi-modality radiomics nomogram based on DCE-MRI and ultrasound images for benign and malignant breast lesion classification.
Liu X; Zhang J; Zhou J; He Y; Xu Y; Zhang Z; Cao G; Miao H; Chen Z; Zhao Y; Jin X; Wang M
Front Oncol; 2022; 12():992509. PubMed ID: 36531052
[TBL] [Abstract][Full Text] [Related]
5. Performance of radiomics models for tumour-infiltrating lymphocyte (TIL) prediction in breast cancer: the role of the dynamic contrast-enhanced (DCE) MRI phase.
Tang WJ; Kong QC; Cheng ZX; Liang YS; Jin Z; Chen LX; Hu WK; Liang YY; Wei XH; Guo Y; Jiang XQ
Eur Radiol; 2022 Feb; 32(2):864-875. PubMed ID: 34430998
[TBL] [Abstract][Full Text] [Related]
6. Role of combined clinical-radiomics model based on contrast-enhanced MRI in predicting the malignancy of breast non-mass enhancements without an additional diffusion-weighted imaging sequence.
Li Y; Yang Z; Lv W; Qin Y; Tang C; Yan X; Yin T; Ai T; Xia L
Quant Imaging Med Surg; 2023 Sep; 13(9):5974-5985. PubMed ID: 37711822
[TBL] [Abstract][Full Text] [Related]
7. Multiparametric MRI model with dynamic contrast-enhanced and diffusion-weighted imaging enables breast cancer diagnosis with high accuracy.
Zhang M; Horvat JV; Bernard-Davila B; Marino MA; Leithner D; Ochoa-Albiztegui RE; Helbich TH; Morris EA; Thakur S; Pinker K
J Magn Reson Imaging; 2019 Mar; 49(3):864-874. PubMed ID: 30375702
[TBL] [Abstract][Full Text] [Related]
8. Development and Validation of a Radiomics Nomogram for Predicting Clinically Significant Prostate Cancer in PI-RADS 3 Lesions.
Li T; Sun L; Li Q; Luo X; Luo M; Xie H; Wang P
Front Oncol; 2021; 11():825429. PubMed ID: 35155214
[TBL] [Abstract][Full Text] [Related]
9. Intra- and Peritumoral Based Radiomics for Assessment of Lymphovascular Invasion in Invasive Breast Cancer.
Jiang W; Meng R; Cheng Y; Wang H; Han T; Qu N; Yu T; Hou Y; Xu S
J Magn Reson Imaging; 2024 Feb; 59(2):613-625. PubMed ID: 37199241
[TBL] [Abstract][Full Text] [Related]
10. Radiomics Based on Multimodal MRI for the Differential Diagnosis of Benign and Malignant Breast Lesions.
Zhang Q; Peng Y; Liu W; Bai J; Zheng J; Yang X; Zhou L
J Magn Reson Imaging; 2020 Aug; 52(2):596-607. PubMed ID: 32061014
[TBL] [Abstract][Full Text] [Related]
11. The value of noncontrast MRI in evaluating breast imaging reporting and data system category 0 lesions on digital mammograms.
Zhang R; Xu M; Zhou C; Ding X; Lu H; Ge M; Du L; Bu Y
Quant Imaging Med Surg; 2022 Aug; 12(8):4069-4080. PubMed ID: 35919041
[TBL] [Abstract][Full Text] [Related]
12. Multiparameter MRI Radiomics Model Predicts Preoperative Peritoneal Carcinomatosis in Ovarian Cancer.
Yu XY; Ren J; Jia Y; Wu H; Niu G; Liu A; Gao Y; Hao F; Xie L
Front Oncol; 2021; 11():765652. PubMed ID: 34790579
[TBL] [Abstract][Full Text] [Related]
13. Value of breast MRI omics features and clinical characteristics in Breast Imaging Reporting and Data System (BI-RADS) category 4 breast lesions: an analysis of radiomics-based diagnosis.
Cui Q; Sun L; Zhang Y; Zhao Z; Li S; Liu Y; Ge H; Qin D; Zhao Y
Ann Transl Med; 2021 Nov; 9(22):1677. PubMed ID: 34988186
[TBL] [Abstract][Full Text] [Related]
14. [Application of MRI-based Radiomics Models in the Assessment of Hepatic Metastasis of Rectal Cancer].
Hu SX; Yang K; Wang XR; Wen DG; Xia CC; Li X; Li ZL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 Mar; 52(2):311-318. PubMed ID: 33829708
[TBL] [Abstract][Full Text] [Related]
15. Contrast-Enhanced Spectral Mammography-Based Radiomics Nomogram for Identifying Benign and Malignant Breast Lesions of Sub-1 cm.
Lin F; Wang Z; Zhang K; Yang P; Ma H; Shi Y; Liu M; Wang Q; Cui J; Mao N; Xie H
Front Oncol; 2020; 10():573630. PubMed ID: 33194677
[TBL] [Abstract][Full Text] [Related]
16. MRI-based radiomics analysis to predict preoperative lymph node metastasis in papillary thyroid carcinoma.
Hu W; Wang H; Wei R; Wang L; Dai Z; Duan S; Ge Y; Wu PY; Song B
Gland Surg; 2020 Oct; 9(5):1214-1226. PubMed ID: 33224796
[TBL] [Abstract][Full Text] [Related]
17. Non-Mass Enhancements on DCE-MRI: Development and Validation of a Radiomics-Based Signature for Breast Cancer Diagnoses.
Li Y; Yang ZL; Lv WZ; Qin YJ; Tang CL; Yan X; Guo YH; Xia LM; Ai T
Front Oncol; 2021; 11():738330. PubMed ID: 34631572
[TBL] [Abstract][Full Text] [Related]
18. Bi-parametric magnetic resonance imaging based radiomics for the identification of benign and malignant prostate lesions: cross-vendor validation.
Ji X; Zhang J; Shi W; He D; Bao J; Wei X; Huang Y; Liu Y; Chen JC; Gao X; Tang Y; Xia W
Phys Eng Sci Med; 2021 Sep; 44(3):745-754. PubMed ID: 34075559
[TBL] [Abstract][Full Text] [Related]
19. Quantitative DWI implemented after DCE-MRI yields increased specificity for BI-RADS 3 and 4 breast lesions.
Dijkstra H; Dorrius MD; Wielema M; Pijnappel RM; Oudkerk M; Sijens PE
J Magn Reson Imaging; 2016 Dec; 44(6):1642-1649. PubMed ID: 27273694
[TBL] [Abstract][Full Text] [Related]
20. Multiparameter MRI Model With DCE-MRI, DWI, and Synthetic MRI Improves the Diagnostic Performance of BI-RADS 4 Lesions.
Sun SY; Ding Y; Li Z; Nie L; Liao C; Liu Y; Zhang J; Zhang D
Front Oncol; 2021; 11():699127. PubMed ID: 34722246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
